TITLE

Pergolide and cabergoline increased risk for valvular heart disease in Parkinson disease

AUTHOR(S)
Zanettini, R.; Antonini, A.; Gatto, G.
PUB. DATE
May 2007
SOURCE
ACP Journal Club;May/Jun2007, Vol. 146 Issue 3, p76
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a study which examines whether pergolide, cabergoline and non-ergot-derived dopamine agonists increase the risk of valvular heart disease in patients with Parkinson's disease. Results revealed that pergolide and cabergoline groups has a higher risk of moderate-to-severe valve regurgitation. The non-ergot-derived dopamine agonists and control groups do not differ from the outcomes. It is concluded that pergolide and cabergoline increased the risk of vascular heart disease.
ACCESSION #
25169129

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics